Why the study?
Does the deletion polymorphism of the ACE gene predict the therapeutic efficacy of captopril on the progression of diabetic nephropathy in patients with insulin dependent diabetes?
Population
35 patients with insulin dependent diabetes and nephropathy treated with captopril for a median of 7 years
Comparison
Homozygous for the deletion allele of the… vs Heterozygous or homozygous for the insertion…
Design
Cohort
Follow-up
median 7 years (range 3-9 years)
Authors
Loading...
Homozygous ACE deletion was associated with steeper GFR decline on captopril; leaves open genotype-guided ACE inhibitor selection.
Does the deletion polymorphism of the ACE gene predict the therapeutic efficacy of captopril on the progression of diabetic nephropathy in patients with insulin dependent diabetes?
The deletion polymorphism in the ACE gene reduces the long-term beneficial effect of ACE inhibition on the progression of diabetic nephropathy in patients with insulin-dependent diabetes.
Parving et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: